尼弗林通过调节PPAR-α/NF-κB通路来缓解急性损伤
Yanying Xiong1, Jin Zhong1, Wenhang Chen2
1Department of Nephropathy, Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Clinical and experimental nephrology
|April 24, 2024
概括
莲花的化合物尼费林通过恢复PPAR-α水平和减少炎症来保护脏免受急性脏损伤 (AKI). 这表明neferine是AKI的潜在治疗剂.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 急性损伤 (AKI) 是一种具有有限治疗选择的危急状况.
- 莲花衍生的类化合物尼费林在缓解AKI方面表现有前途,但其机制尚不清楚.
- 过氧体增殖器激活受体α (PPAR-α) 具有抗炎作用,并调节脂质代谢.
研究的目的:
- 调查PPAR-α在尼费林对AKI的保护作用中的作用.
- 在AKI模型中阐明neferine在AKI模型中发挥其保护作用的分子通路.
主要方法:
- 使用的细胞 (NRK-52E) 和小鼠模型,通过缺血/反 (I/R) 或脂多糖 (LPS) 诱导的AKI.
- 评估了neferine预处理对NF-κB通路激活,PPAR-α表达,TNF-α产生和脂质代谢的影响.
- 使用PPAR-α过度表达和siRNA介导的沉默来确定其功能意义.
主要成果:
- 在I/R和LPS诱导的AKI模型中,尼费林抑制了NF-κB激活,并逆转了PPAR-α缺乏.
- 过度表达PPAR-α抑制了NF-κB和TNF-α,而抑制PPAR-α则取消了neferine的抗炎作用.
- 尼费林减少了LPS治疗细胞中的脂质积累和正常化的FAO相关酶表达.
结论:
- 尼费林在AKI中的保护作用部分通过恢复的PPAR-α表达来调解.
- 尼费林通过PPAR-α抑制炎症性NF-κB通路,为AKI提供了潜在的治疗策略.
- 用尼弗林向脏PPAR-α为AKI治疗提供了一个有前途的途径.
相关概念视频
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Nephrons
2.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.4K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Dialysis
302
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
302
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Antihypertensive Drugs: Direct Renin Inhibitors
606
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
606


